MoneyWorks4Me

Jagsonpal Pharmaceuticals informs about certificate

20 Jul 2022 Evaluate

In Compliance with Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018, Jagsonpal Pharmaceuticals forwarded a copy of the Certificate received from MCS Share Transfer Agent, the Registrar and Share Transfer Agent of the Company, for the quarter ended 30th June, 2022.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1752.10
Dr. Reddys Labs. 1232.90
Cipla 1330.60
Lupin 1966.30
Zydus Lifesciences 1123.10
View more..